Dreem is a pioneering brain health company, building the first integrated sleep care program to provide affordable, personalized and safe care at scale - and to address the $1T annual economic loss due to sleep disorders.
We have raised $60M from investors including Johnson & Johnson and have a team of 100 people based in New York and Paris.
Dreem has developed a new gold standard for the treatment of sleep troubles combining:
A Headband (a home assessment that& monitorsmonitoring of sleep + provides neurofeedback/biofeedback)
An Interactive App (digital therapy personalized with user’s data)
Experts (remote consultations with trained sleep experts enabled by our platform)
We have generated real world evidence from thousands of people, and have demonstrated best-in-class performance when compared to medication and psychotherapy. Our program additionally extends to other therapeutic applications, including sleep apnea and mental health.